nitinol and Urinary-Retention

nitinol has been researched along with Urinary-Retention* in 1 studies

Reviews

1 review(s) available for nitinol and Urinary-Retention

ArticleYear
What's New in TIND?
    European urology focus, 2018, Volume: 4, Issue:1

    There is growing interest in minimally invasive (MI) treatment options for male lower urinary tract symptoms (LUTS). Among these options, the temporary implantable nitinol device (TIND; Medi-Tate, Or Akiva, Israel) is a novel instrument used to alleviate symptoms by creating incisions in the prostate via mechanical stress.. To review recent data for TIND as an MI procedure to improve LUTS.. Medline, PubMed, the Cochrane Database, and Embase were screened for clinical trials, randomized controlled trials, and review articles on the use of TIND in patients with male LUTS.. Preliminary data suggest that TIND is a safe and effective MI technique for patients with male LUTS. Symptom relief and increase in urinary flow after 36mo are promising. However, long-term results are needed.. Various treatment options for male patients suffering from urinary voiding symptoms are emerging. TIND, a temporary implantable nitinol device, appears to be a safe option that improves symptoms without affecting sexuality.

    Topics: Alloys; Clinical Trials as Topic; Humans; Israel; Lower Urinary Tract Symptoms; Male; Minimally Invasive Surgical Procedures; Postoperative Complications; Prostate; Prostatic Hyperplasia; Prostheses and Implants; Randomized Controlled Trials as Topic; Stress, Mechanical; Urinary Retention; Urinary Tract Infections

2018